$ICUI
ICU Medical Inc Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000088398417000043 Filed on August 09, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$331.5M	$96.72M
YoY Change	242.75%	15.45%
Cost Of Revenue	$243.5M	$46.59M
YoY Change	422.55%	16.41%
Gross Profit	$88.06M	$50.13M
YoY Change	75.66%	14.56%
Gross Profit Margin	26.56%	51.83%
Selling, General & Admin	$85.11M	$22.49M
YoY Change	278.4%	10.69%
% of Gross Profit	96.64%	44.86%
Research & Development	$12.97M	$3.338M
YoY Change	288.47%	6.92%
% of Gross Profit	14.72%	6.66%
Depreciation & Amortization	$14.40M	$4.800M
YoY Change	200.0%	9.09%
% of Gross Profit	16.35%	9.57%
Operating Expenses	$124.0M	$27.36M
YoY Change	353.16%	16.73%
Operating Profit	-$35.93M	$22.77M
YoY Change	-257.8%	12.05%
Interest Expense	$525.0K	$48.00K
YoY Change	993.75%
% of Operating Profit		0.21%
Other Income/Expense, Net	-$2.720M	$125.0K
YoY Change	-2276.0%	-47.92%
Pretax Income	-$39.18M	$23.96M
YoY Change	-263.53%	16.52%
Income Tax	-$2.117M	$7.351M
% Of Pretax Income		30.68%
Net Earnings	-$37.06M	$16.61M
YoY Change	-323.17%	22.37%
Net Earnings / Revenue	-11.18%	17.17%
Basic Earnings Per Share	-$1.87	$1.03
Diluted Earnings Per Share	-$1.87	$0.98
COMMON SHARES
Basic Shares Outstanding	19.82M shares	16.09M shares
Diluted Shares Outstanding	19.82M shares	17.00M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$240.9M	$400.6M
YoY Change	-39.87%	9.07%
Cash & Equivalents	$240.9M	$372.9M
Short-Term Investments		$27.70M
Other Short-Term Assets	$5.793M	$12.30M
YoY Change	-52.9%	-10.87%
Inventory	$401.3M	$49.92M
Prepaid Expenses
Receivables	$124.9M	$60.49M
Other Receivables	$13.40M	$12.10M
Total Short-Term Assets	$904.4M	$535.4M
YoY Change	68.93%	13.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$374.6M	$79.70M
YoY Change	369.98%	-2.05%
Goodwill	$6.652M	$6.245M
YoY Change	6.52%	322.53%
Intangibles	$160.3M	$23.18M
YoY Change	591.65%	261.39%
Long-Term Investments
YoY Change
Other Assets	$29.68M	$18.90M
YoY Change	57.03%	90.91%
Total Long-Term Assets	$582.9M	$128.0M
YoY Change	355.42%	29.04%
TOTAL ASSETS
Total Short-Term Assets	$904.4M	$535.4M
Total Long-Term Assets	$582.9M	$128.0M
Total Assets	$1.487B	$663.4M
YoY Change	124.2%	16.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$40.44M	$18.85M
YoY Change	114.52%	49.78%
Accrued Expenses	$146.3M	$21.76M
YoY Change	572.44%	35.23%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00
YoY Change
Total Short-Term Liabilities	$189.1M	$40.61M
YoY Change	365.61%	41.62%
LONG-TERM LIABILITIES
Long-Term Debt	$75.00M	$0.00
YoY Change
Other Long-Term Liabilities	$97.50M	$2.800M
YoY Change	3382.14%	133.33%
Total Long-Term Liabilities	$75.00M	$2.800M
YoY Change	2578.57%	133.33%
TOTAL LIABILITIES
Total Short-Term Liabilities	$189.1M	$40.61M
Total Long-Term Liabilities	$75.00M	$2.800M
Total Liabilities	$264.1M	$47.20M
YoY Change	459.52%	46.58%
SHAREHOLDERS EQUITY
Retained Earnings	$535.8M	$488.7M
YoY Change	9.64%	13.07%
Common Stock	$594.9M	$151.0M
YoY Change	294.1%	22.07%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$15.00K	$4.471M
YoY Change	-99.66%
Treasury Stock Shares	90.00 shares	50.00K shares
Shareholders Equity	$1.121B	$616.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.487B	$663.4M
YoY Change	124.2%	16.33%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	-$37.06M	$16.61M
YoY Change	-323.17%	22.37%
Depreciation, Depletion And Amortization	$14.40M	$4.800M
YoY Change	200.0%	9.09%
Cash From Operating Activities	$47.70M	$24.50M
YoY Change	94.69%	54.09%
INVESTING ACTIVITIES
Capital Expenditures	-$12.40M	-$5.400M
YoY Change	129.63%	92.86%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$6.400M
YoY Change	-100.0%	-35.35%
Cash From Investing Activities	-$12.40M	$800.0K
YoY Change	-1650.0%	-88.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.900M	2.400M
YoY Change	-20.83%	-220.0%
NET CHANGE
Cash From Operating Activities	47.70M	24.50M
Cash From Investing Activities	-12.40M	800.0K
Cash From Financing Activities	1.900M	2.400M
Net Change In Cash	37.20M	27.70M
YoY Change	34.3%	31.9%
FREE CASH FLOW
Cash From Operating Activities	$47.70M	$24.50M
Capital Expenditures	-$12.40M	-$5.400M
Free Cash Flow	$60.10M	$29.90M
YoY Change	101.0%	59.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	19977602	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE
CY2016Q4	icui	Accrued Product Liability AccruedProductLiability	0	USD
CY2017Q2	icui	Accrued Product Liability AccruedProductLiability	14151000	USD
CY2016Q4	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	5702000	USD
CY2017Q2	icui	Accrued Salaries And Benefits AccruedSalariesAndBenefits	54674000	USD
CY2016Q4	icui	Accruedlegalfees Accruedlegalfees	4177000	USD
CY2017Q2	icui	Accruedlegalfees Accruedlegalfees	2585000	USD
	icui	Bargainpurchasegainnoncashaddback Bargainpurchasegainnoncashaddback	1110000	USD
	icui	Bargainpurchasegainnoncashaddback Bargainpurchasegainnoncashaddback	63237000	USD
	icui	Business Combination Consideration Transferred Equity Issued Fair Value BusinessCombinationConsiderationTransferredEquityIssuedFairValue	0	USD
CY2017Q2	icui	Business Combination Consideration Transferred Equity Issued Fair Value BusinessCombinationConsiderationTransferredEquityIssuedFairValue	413139000	USD
	icui	Business Combination Consideration Transferred Equity Issued Fair Value BusinessCombinationConsiderationTransferredEquityIssuedFairValue	413139000	USD
CY2017Q2	icui	Contingentconsiderationgross Contingentconsiderationgross	225000000	USD
CY2017Q2	icui	Discountonequityissuedasconsideration Discountonequityissuedasconsideration	37261000	USD
CY2017Q2	icui	Earnout Target EarnoutTarget	1000000000	USD
	icui	Estimatedworkingcapitaladjustment Estimatedworkingcapitaladjustment	0	USD
	icui	Estimatedworkingcapitaladjustment Estimatedworkingcapitaladjustment	7512000	USD
	icui	Fair Value Assumptions Costof Debt FairValueAssumptionsCostofDebt	0.0416
	icui	Fair Value Assumptions Expected Volatility Rate Adjusted Ebitda FairValueAssumptionsExpectedVolatilityRateAdjustedEBITDA	0.2900
	icui	Fair Value Assumptions Market Priceof Risk FairValueAssumptionsMarketPriceofRisk	0.0693
	icui	Fee Cap First Twelve Months FeeCapFirstTwelveMonths	62500000	USD
	icui	Fee Cap Sixmonthssubsequenttofirsttwelvemonths FeeCapSixmonthssubsequenttofirsttwelvemonths	31300000	USD
	icui	Incometaxexcesstaxbenefitadjustment Asu201609 Adoption IncometaxexcesstaxbenefitadjustmentASU201609Adoption	3100000	USD
	icui	Incometaxexcesstaxbenefitadjustment Asu201609 Adoption IncometaxexcesstaxbenefitadjustmentASU201609Adoption	9900000	USD
	icui	Increase Decreasein Assumed Liabilities IncreaseDecreaseinAssumedLiabilities	-362000	USD
	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	4793000	USD
	icui	Increase Decreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes IncreaseDecreaseinincometaxesincludingexcesstaxbenefitsanddeferredincometaxes	-14185000	USD
CY2016Q4	icui	Liabilitiesforcontracts Liabilitiesforcontracts	0	USD
CY2017Q2	icui	Liabilitiesforcontracts Liabilitiesforcontracts	56948000	USD
CY2016Q4	icui	Miscellaneousacquisitionrelatedaccrual Miscellaneousacquisitionrelatedaccrual	2750000	USD
CY2017Q2	icui	Miscellaneousacquisitionrelatedaccrual Miscellaneousacquisitionrelatedaccrual	0	USD
	icui	Net Cash Paid Receivedforcurrentandprioracquisitions NetCashPaidReceivedforcurrentandprioracquisitions	2606000	USD
	icui	Net Cash Paid Receivedforcurrentandprioracquisitions NetCashPaidReceivedforcurrentandprioracquisitions	157097000	USD
CY2016Q4	icui	Outsidesalescommissions Outsidesalescommissions	1141000	USD
CY2017Q2	icui	Outsidesalescommissions Outsidesalescommissions	1763000	USD
CY2017Q2	icui	Paymenttoacquirebusinessnetofworkingcapitaladjustments Paymenttoacquirebusinessnetofworkingcapitaladjustments	177527000	USD
CY2016Q4	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	1649000	USD
CY2017Q2	icui	Prepaidinsuranceandpropertytaxes Prepaidinsuranceandpropertytaxes	3727000	USD
CY2016Q4	icui	Prepaidothertaxes Prepaidothertaxes	1018000	USD
CY2017Q2	icui	Prepaidothertaxes Prepaidothertaxes	2712000	USD
CY2016Q4	icui	Prepaids Hi Stransaction PrepaidsHIStransaction	0	USD
CY2017Q2	icui	Prepaids Hi Stransaction PrepaidsHIStransaction	31084000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	158259000	USD
	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	-125000	USD
	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	2031000	USD
CY2016Q2	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	1533000	USD
	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	1533000	USD
CY2017Q2	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	19921000	USD
	icui	Restructuringandstrategictransaction Restructuringandstrategictransaction	49322000	USD
CY2016Q2	icui	Strategic Transaction Costs StrategicTransactionCosts	1100000	USD
	icui	Strategictransactionexpenses Strategictransactionexpenses	1100000	USD
CY2017Q2	icui	Strategictransactionexpenses Strategictransactionexpenses	12400000	USD
	icui	Strategictransactionexpenses Strategictransactionexpenses	33500000	USD
	icui	Thirdparty Inventory ThirdpartyInventory	0	USD
CY2017Q2	icui	Thirdparty Inventory ThirdpartyInventory	13078000	USD
	icui	Transitional Service Agreement Setup Costs TransitionalServiceAgreementSetupCosts	22000000	USD
CY2017Q2	icui	Treasury Stock Purchase Plan TreasuryStockPurchasePlan	40000000	USD
CY2017Q2	icui	Treasury Stock Purchase Plan Remaining Available TreasuryStockPurchasePlanRemainingAvailable	7200000	USD
CY2017Q2	invest	Derivative Notional Amount DerivativeNotionalAmount	690300000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14641000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	40443000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	56161000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	124934000	USD
CY2016Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	7912000	USD
CY2017Q2	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	17487000	USD
CY2016Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	1107000	USD
CY2017Q2	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	4732000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2017Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2333000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1519000	USD
CY2017Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	1519000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	25896000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	146317000	USD
CY2016Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	0	USD
CY2017Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2125000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	182366000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	0	USD
CY2017Q2	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	2816000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-21272000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9387000	USD
CY2017Q2	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P9Y0M
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	162828000	USD
CY2017Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	592953000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1073000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3042000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7300000	USD
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6239	shares
CY2016Q4	us-gaap	Assets Assets	704688000	USD
CY2017Q2	us-gaap	Assets Assets	1487297000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	569097000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	904433000	USD
CY2017Q2	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	2508000	USD
CY2016Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2017Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	2508000	USD
	us-gaap	Business Acquisition Equity Interests Issued Or Issuable Number Of Shares Issued BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued	3200000	shares
CY2017Q2	us-gaap	Business Acquisition Share Price BusinessAcquisitionSharePrice	140.75
CY2017Q2	us-gaap	Business Combination Acquired Receivables Fair Value BusinessCombinationAcquiredReceivablesFairValue	362000	USD
CY2016Q2	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	1110000	USD
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	1110000	USD
CY2017Q2	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	0	USD
	us-gaap	Business Combination Bargain Purchase Gain Recognized Amount BusinessCombinationBargainPurchaseGainRecognizedAmount	63237000	USD
CY2017Q2	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	684666000	USD
CY2017Q2	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	450400000	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	6000000	USD
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	6000000	USD
CY2016Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	USD
CY2017Q2	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	19000000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	29475000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	4766000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	12381000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	54794000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent	27101000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Indefinite Lived Intangible Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets	5000000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	139000000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	417317000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	775004000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	68510000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther	31283000	USD
CY2017Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	288486000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1574000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6024000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	336164000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	372895000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	445082000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240923000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	36731000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-204159000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	16338000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19844000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	16338000	shares
CY2017Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19844000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1633000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	1984000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14339000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36598000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27204000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30688000	USD
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	15180000	USD
CY2017Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	36861000	USD
CY2017Q2	us-gaap	Contractual Obligation ContractualObligation	219293000	USD
CY2017Q2	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	9551000	USD
CY2017Q2	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	42434000	USD
CY2017Q2	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	113370000	USD
CY2017Q2	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	15937000	USD
CY2017Q2	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	22789000	USD
CY2017Q2	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	15212000	USD
CY2016Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2017Q2	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	46589000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	87211000	USD
CY2017Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	243452000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	402246000	USD
	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	Interest on the Senior Note is variable and will accrue at LIBOR plus (i) 2.25% per year for the first 12 months, and (ii) 2.50% per annum thereafter.
	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2020-02-03
	us-gaap	Debt Instrument Restrictive Covenants DebtInstrumentRestrictiveCovenants	The Senior Note has restrictions, beginning on the effective date and thereafter, pertaining to limitations on debt, liens, loans, advances, acquisitions, other investments, dividends, redemptions, repurchases of equity interests, fundamental changes in the line of business, dispositions, transactions with affiliates, dividend and payment restrictions affecting subsidiaries, changes in line of business and accounting changes or change in fiscal year.
CY2017Q2	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	75000000	USD
CY2016Q4	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	18000	USD
CY2017Q2	us-gaap	Deferred Revenue And Credits Current DeferredRevenueAndCreditsCurrent	3697000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	148000	USD
CY2017Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5678000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	21935000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	11597000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1370000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	4428000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9648000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29906000	USD
CY2017Q2	us-gaap	Derivative Forward Exchange Rate1 DerivativeForwardExchangeRate1	20.01
CY2016Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2017Q2	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	22000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	22000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.16
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.98
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.05
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.93
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1445000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	2473000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.28
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.82
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
	us-gaap	Fair Value Assumptions Risk Free Interest Rate FairValueAssumptionsRiskFreeInterestRate	0.0282
	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.1000
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	6000000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	19000000	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2017Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	25000000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	3572000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	881732000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24542000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23304000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	78493000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	8640000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	16521000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	16604000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	16743000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	17156000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	46925000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	177461000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22383000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	154157000	USD
CY2017Q2	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	1000000	USD
CY2017Q2	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	1804000	USD
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	3243000	USD
CY2017Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	4021000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-31000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3010000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	5577000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	6652000	USD
CY2017Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1015000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	1015000	USD
CY2017Q2	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	60000	USD
	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	-218000	USD
CY2017Q2	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	50132000	USD
	us-gaap	Gross Profit GrossProfit	99365000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	88062000	USD
	us-gaap	Gross Profit GrossProfit	177007000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23957000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	48049000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39177000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	6671000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7351000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13283000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2117000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12132000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3752000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8785000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2527000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	70606000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-5985000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	66479000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5479000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-66870000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3784000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	95254000	USD
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	909000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	894000	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1159000	shares
CY2017Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	6189000	USD
CY2017Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	183650000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22383000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	160346000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	48000	USD
	us-gaap	Interest Expense InterestExpense	77000	USD
CY2017Q2	us-gaap	Interest Expense InterestExpense	525000	USD
	us-gaap	Interest Expense InterestExpense	1038000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16414000	USD
CY2017Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	253420000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	49264000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	401312000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	28435000	USD
CY2017Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	83440000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	4415000	USD
CY2017Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	64452000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	121000	USD
	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	0	USD
CY2016Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	100000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
CY2017Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1800000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3000000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	704688000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1487297000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	162786000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	40537000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	189093000	USD
CY2016Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	1107000	USD
CY2017Q2	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent	70939000	USD
CY2017Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	75000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	75000000	USD
CY2016Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	96536000	USD
CY2017Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	222658000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7918000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8531000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1429000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-186299000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41775000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28864000	USD
CY2016Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	125000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	301000	USD
CY2017Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2720000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2613000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	27362000	USD
	us-gaap	Operating Expenses OperatingExpenses	52650000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	123994000	USD
	us-gaap	Operating Expenses OperatingExpenses	229922000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	22770000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	46715000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-35932000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3216000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-52915000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	34258000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	4300000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	3316000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5591000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8284000	USD
CY2017Q2	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	9551000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2301000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18565000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	0	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	459000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1740000	USD
CY2017Q2	us-gaap	Other Assets Current OtherAssetsCurrent	5793000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	29679000	USD
CY2017Q2	us-gaap	Other Commitment OtherCommitment	8181000	USD
CY2017Q2	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	0	USD
CY2017Q2	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	0	USD
CY2017Q2	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	297000	USD
CY2017Q2	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	3176000	USD
CY2017Q2	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	3193000	USD
CY2017Q2	us-gaap	Other Commitments Future Minimum Payments Remainder Of Fiscal Year OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear	1515000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	0	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1119000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1119000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	0	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	0	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	685000	USD
	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax	685000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2267000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1832000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8888000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	10914000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	746000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	413000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-8000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-56000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2267000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1832000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	9856000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	11885000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	151000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1197000	USD
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1326000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	0	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	0	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	1804000	USD
CY2016Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	2948000	USD
CY2017Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	6996000	USD
CY2016Q4	us-gaap	Other Receivables OtherReceivables	0	USD
CY2017Q2	us-gaap	Other Receivables OtherReceivables	71046000	USD
CY2016Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	9000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	15000	USD
CY2017Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	296000	USD
	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	792000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16911000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3739000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	9563000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3700000	USD
CY2017Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	260000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2606000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	157097000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	513000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2005000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18106000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9112000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	27199000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7355000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	121358000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	11235000	USD
CY2017Q2	us-gaap	Prepaid Taxes PrepaidTaxes	13398000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2017Q2	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	75000000	USD
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	75000000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	31765000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7796000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	0	USD
CY2017Q2	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1245000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10944000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	0	USD
CY2017Q2	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3122000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	16606000	USD
	us-gaap	Profit Loss ProfitLoss	34766000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	-37060000	USD
	us-gaap	Profit Loss ProfitLoss	18803000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	243955000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	556956000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	85696000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	374590000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1925000	USD
CY2017Q2	us-gaap	Purchase Obligation PurchaseObligation	101854000	USD
CY2017Q2	us-gaap	Purchase Obligation Due After Fifth Year PurchaseObligationDueAfterFifthYear	0	USD
CY2017Q2	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	39218000	USD
CY2017Q2	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	34757000	USD
CY2017Q2	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	9397000	USD
CY2017Q2	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	4477000	USD
CY2017Q2	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	14005000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3338000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6651000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	12967000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24608000	USD
	us-gaap	Restructuring Charges RestructuringCharges	15826000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	1530000	USD
CY2017Q2	us-gaap	Restructuring Reserve RestructuringReserve	5824000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-1969000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	423000	USD
CY2017Q2	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	4905000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	516980000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	535783000	USD
CY2016Q2	us-gaap	Revenues Revenues	96721000	USD
	us-gaap	Revenues Revenues	186576000	USD
CY2017Q2	us-gaap	Revenues Revenues	331514000	USD
	us-gaap	Revenues Revenues	579253000	USD
CY2016Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	1472000	USD
CY2017Q2	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	5369000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	96712000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	186561000	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	331218000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	578461000	USD
CY2016Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	0	USD
CY2017Q2	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	3857000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22491000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44466000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85106000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	149992000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7674000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	8805000	USD
	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	25864	shares
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	660155000	USD
CY2017Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1121318000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	93	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	90	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	14000	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	15000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16964000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19821000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20312000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16091000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16070000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19821000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19153000	shares
	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Standards</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In May 2017, the FASB issued ASU No. 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting. The amendments in this update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. Under the ASU, an entity will account for the effects of a modification unless (i) the fair value of the modified award is the same as the fair value of the original award immediately before the original award is modified, (ii) the vesting conditions of the modified award are the same vesting conditions as the original award immediately before the original award is modified, and (iii) the classification of the modified award as an equity instrument or a liability instrument is the same as the classification of the original award immediately before the original award is modified. The amendments in this ASU are effective prospectively for annual periods, and interim periods within those annual periods, beginning December 15, 2017. This ASU is not expected to have a material impact on our condensed consolidated financial statements or related footnote disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-04, Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The amendments in this update remove the second step of the impairment test. An entity will apply a one-step quantitative test and record the amount of goodwill impairment as the excess of a reporting unit's carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit. The new guidance does not amend the optional qualitative assessment of goodwill impairment. The amendments in ASU 2017-04 are effective for the annual or interim impairment test in fiscal years beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. This ASU is not expected to have a material impact on our condensed consolidated financial statements or related footnote disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition of a Business. The amendments in this update clarify the definition of a business with the objective of adding guidance to assist entities with evaluating whether transactions should be accounted for as acquisitions (or disposals) of assets or businesses. The amendments in this update provide a screen to determine when a set (integrated set of assets and activities) is not a business.  If the screen is not met, it (1) requires that to be considered a business, a set must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output and (2) removes the evaluation of whether a market participant could replace the missing elements. The amendments in ASU 2017-01 are effective for annual periods and interim periods within those annual periods beginning after December 15, 2017. The amendments in this ASU should be applied prospectively on or after the effective date. This ASU is not expected to have a material impact on our condensed consolidated financial statements or related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory. Current generally accepted accounting principles prohibits the recognition of current and deferred income taxes for an intra-entity asset transfer until after the asset has been sold to an outside party. The amendments in ASU 2016-16 eliminates this prohibition, accordingly an entity should recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. Amendments in this update are effective for annual reporting periods beginning after December 15, 2017. Early adoption is permitted in the first interim period of an annual reporting period. The amendments should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"></font><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments. ASU 2016-15</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">provides specific guidance on eight cash flow issues where current guidance is unclear or does not include any specifics on classification. The eight specific cash flow issues are: debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with zero coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies, including bank-owned policies; distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. The amendments in ASU 2016-15 are effective for annual periods and interim periods within those annual periods beginning after December 15, 2017. Early adoption is permitted. If adopted in an interim period, any adjustments should be reflected as of the beginning of the fiscal year that includes the interim period. Amendments should be applied using a retrospective transition method to each period presented. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. This update amends the FASB's guidance on the impairment of financial instruments by requiring timelier recording of credit losses on loans and other financial instruments. The ASU adds an impairment model that is based on expected losses rather than incurred losses. The ASU also amends the accounting for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted as of the fiscal years beginning after December 15, 2018. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842). The amendments in this update require an entity to recognize a right-of-use asset and lease liability for all leases with terms of more than 12 months. Recognition, measurement and presentation of expenses will depend on classification as finance or operating lease. The amendments also require certain quantitative and qualitative disclosures about leasing arrangements. The amendments in this update will be effective for fiscal years beginning after December 15, 2019. Early adoption is permitted. The updated guidance requires a modified retrospective adoption. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities, which amends certain aspects of recognition, measurement, presentation and disclosure of financial instruments. This amendment requires all equity investments to be measured at fair value with changes in the fair value recognized through net income (other than those accounted for under the equity method of accounting or those that result in the consolidation of the investee). The amendments in this update will be effective for fiscal years beginning after December 15, 2017. Early adoption of the amendments is not permitted with the exception of the provision requiring the recognition in other comprehensive income the fair value change from instrument-specific credit risk measured using the fair value option for financial instruments. We are currently evaluating the impact of this ASU on the consolidated financial statements and related disclosures. </font></div><div style="line-height:120%;text-align:left;text-indent:96px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">        </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU 2014-09 removes inconsistencies and weaknesses in revenue requirements, provides a more robust framework for addressing revenue issues, improves comparability of revenue recognition practices across entities, industries, jurisdictions and capital markets, provides more useful information to users of financial statements through improved disclosure requirements and simplifies the preparation of financial statements by reducing the number of requirements to which an entity must refer. This guidance requires that an entity depict the consideration by applying a five-step analysis in determining when and how revenue is recognized. The new model will require revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services. On April 1, 2015, the FASB voted for a one-year deferral of the effective date of the new revenue recognition standard, ASU 2014-09.  On July 15, 2015, the FASB affirmed these changes, which requires public entities to apply the amendments in ASU 2014-09 for annual reporting beginning after December 15, 2017. Early adoption is permitted beginning after December 31, 2016, the original effective date in ASU 2014-09. Subsequent to the issuance of this ASU, the FASB issued three amendments: ASU No. 2016-08 which clarifies principal versus agent considerations; ASU 2016-10 which clarifies guidance related to identifying performance obligations and licensing implementation; and ASU 2016-12 which provides narrow-scope improvements and practical expedients. All of the amendments have the same effective dates mentioned above. We previously disclosed that we did not anticipate a material impact on our consolidated financial statements from adoption of any of the above. In light of the Hospira Infusion Systems ("HIS") acquisition we are reevaluating the impact of this ASU on our consolidated financial statements. We expect to have enhanced disclosures upon adoption of this ASU. We now expect to adopt the modified restrospective method when adopting this ASU.</font></div></div>

Files In Submission

Name	View Source	Status
0000883984-17-000043-index-headers.html	Edgar Link	pending
0000883984-17-000043-index.html	Edgar Link	pending
0000883984-17-000043.txt	Edgar Link	pending
0000883984-17-000043-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icui-20170630.xml	Edgar Link	completed
icui-20170630.xsd	Edgar Link	pending
icui-20170630_cal.xml	Edgar Link	unprocessable
icui-20170630_def.xml	Edgar Link	unprocessable
icui-20170630_lab.xml	Edgar Link	unprocessable
icui-20170630_pre.xml	Edgar Link	unprocessable
icui-ex311_20170630x10q.htm	Edgar Link	pending
icui-ex312_x20170630x10q.htm	Edgar Link	pending
icui-ex321_x20170630x10q.htm	Edgar Link	pending
icui0630201710-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU Medical Inc Stock $icui

2017 Q2 Form 10-Q Financial Statement

#000088398417000043 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU Medical Inc Stock $icui

2017 Q2 Form 10-Q Financial Statement

#000088398417000043 Filed on August 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU Medical Inc Stock $icui